{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:55:17Z","timestamp":1787003717742,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL120822"],"award-info":[{"award-number":["T32HL120822"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK092926"],"award-info":[{"award-number":["P30DK092926"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47839-2","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T09:14:06Z","timestamp":1778404446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PNPLA3-I148M reduces hepatic triacylglycerol secretion and mitigates diet induced left ventricular diastolic dysfunction"],"prefix":"10.1038","volume":"16","author":[{"given":"Andrew J.","family":"Butcko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehinde A.","family":"Adeshina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parsa","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Teskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir A.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer V.","family":"Jaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhlesh K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Granneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio P.","family":"Mottillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,10]]},"reference":[{"key":"47839_CR1","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi, Z. et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 69, 2672\u20132682. https:\/\/doi.org\/10.1002\/hep.30251 (2019).","journal-title":"Hepatology"},{"key":"47839_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"47839_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","volume":"68","author":"M Eslam","year":"2018","unstructured":"Eslam, M., Valenti, L. & Romeo, S. Genetics and epigenetics of NAFLD and NASH: Clinical impact. J. Hepatol. 68, 268\u2013279. https:\/\/doi.org\/10.1016\/j.jhep.2017.09.003 (2018).","journal-title":"J. Hepatol."},{"key":"47839_CR4","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.jhepr.2024.101133","volume":"6","author":"H Wu","year":"2024","unstructured":"Wu, H. et al. Dietary pattern modifies the risk of MASLD through metabolomic signature. JHEP Rep. 6, 101133. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101133 (2024).","journal-title":"JHEP Rep."},{"key":"47839_CR5","doi-asserted-by":"publisher","unstructured":"Mosca, A. et al. Environment, endocrine disruptors, and fatty liver disease associated with metabolic dysfunction (MASLD). Metabolites. 14 https:\/\/doi.org\/10.3390\/metabo14010071 (2024).","DOI":"10.3390\/metabo14010071"},{"key":"47839_CR6","doi-asserted-by":"publisher","first-page":"101143","DOI":"10.1016\/j.molmet.2020.101143","volume":"50","author":"KK Bence","year":"2021","unstructured":"Bence, K. K. & Birnbaum, M. J. Metabolic drivers of non-alcoholic fatty liver disease. Mol. Metab. 50, 101143. https:\/\/doi.org\/10.1016\/j.molmet.2020.101143 (2021).","journal-title":"Mol. Metab."},{"key":"47839_CR7","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/hep.24283","volume":"53","author":"S Sookoian","year":"2011","unstructured":"Sookoian, S. & Pirola, C. J. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 53, 1883\u20131894. https:\/\/doi.org\/10.1002\/hep.24283 (2011).","journal-title":"Hepatology"},{"key":"47839_CR8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jhep.2020.01.029","volume":"72","author":"RW Walker","year":"2020","unstructured":"Walker, R. W. et al. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank. J. Hepatol. 72, 1070\u20131081. https:\/\/doi.org\/10.1016\/j.jhep.2020.01.029 (2020).","journal-title":"J. Hepatol."},{"key":"47839_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12902-021-00789-4","volume":"21","author":"N Salari","year":"2021","unstructured":"Salari, N. et al. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis. BMC Endocr. Disord. 21, 125. https:\/\/doi.org\/10.1186\/s12902-021-00789-4 (2021).","journal-title":"BMC Endocr. Disord"},{"key":"47839_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5009\/gnl240407","volume":"19","author":"Y Pei","year":"2025","unstructured":"Pei, Y. & Goh, G. B. Genetic risk factors for metabolic dysfunction-associated steatotic liver disease. Gut Liver. 19, 8\u201318. https:\/\/doi.org\/10.5009\/gnl240407 (2025).","journal-title":"Gut Liver"},{"key":"47839_CR11","doi-asserted-by":"publisher","first-page":"e16123","DOI":"10.1111\/liv.16123","volume":"45","author":"J Kozlitina","year":"2025","unstructured":"Kozlitina, J. & Sookoian, S. Global epidemiological impact of PNPLA3 I148M on liver disease. Liver Int. 45, e16123. https:\/\/doi.org\/10.1111\/liv.16123 (2025).","journal-title":"Liver Int."},{"key":"47839_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.cmet.2012.04.008","volume":"15","author":"M Kumari","year":"2012","unstructured":"Kumari, M. et al. Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase. Cell. Metab. 15, 691\u2013702. https:\/\/doi.org\/10.1016\/j.cmet.2012.04.008 (2012).","journal-title":"Cell. Metab."},{"key":"47839_CR13","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1074\/jbc.RA118.002333","volume":"293","author":"MA Mitsche","year":"2018","unstructured":"Mitsche, M. A., Hobbs, H. H. & Cohen, J. C. Patatin-like phospholipase domain-containing protein 3 promotes transfer of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets. J. Biol. Chem. 293, 6958\u20136968. https:\/\/doi.org\/10.1074\/jbc.RA118.002333 (2018).","journal-title":"J. Biol. Chem."},{"key":"47839_CR14","doi-asserted-by":"publisher","unstructured":"Luukkonen, P. K. et al. Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids. JCI Insight. 4 https:\/\/doi.org\/10.1172\/jci.insight.127902 (2019).","DOI":"10.1172\/jci.insight.127902"},{"key":"47839_CR15","doi-asserted-by":"publisher","first-page":"159410","DOI":"10.1016\/j.bbalip.2023.159410","volume":"1869","author":"M Colaco-Gaspar","year":"2024","unstructured":"Colaco-Gaspar, M., Hofer, P., Oberer, M. & Zechner, R. PNPLA-mediated lipid hydrolysis and transacylation\u2014At the intersection of catabolism and anabolism. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids. 1869, 159410. https:\/\/doi.org\/10.1016\/j.bbalip.2023.159410 (2024).","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"47839_CR16","doi-asserted-by":"publisher","first-page":"37085","DOI":"10.1074\/jbc.M111.290114","volume":"286","author":"Y Huang","year":"2011","unstructured":"Huang, Y., Cohen, J. C. & Hobbs, H. H. Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. J. Biol. Chem. 286, 37085\u201337093. https:\/\/doi.org\/10.1074\/jbc.M111.290114 (2011).","journal-title":"J. Biol. Chem."},{"key":"47839_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.plipres.2013.10.001","volume":"53","author":"A Yamashita","year":"2014","unstructured":"Yamashita, A. et al. Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and model organisms. Prog. Lipid Res. 53, 18\u201381. https:\/\/doi.org\/10.1016\/j.plipres.2013.10.001 (2014).","journal-title":"Prog. Lipid Res."},{"key":"47839_CR18","doi-asserted-by":"publisher","first-page":"6706","DOI":"10.1074\/jbc.M109.064501","volume":"285","author":"S He","year":"2010","unstructured":"He, S. et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J. Biol. Chem. 285, 6706\u20136715. https:\/\/doi.org\/10.1074\/jbc.M109.064501 (2010).","journal-title":"J. Biol. Chem."},{"key":"47839_CR19","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/hep.23812","volume":"52","author":"W Chen","year":"2010","unstructured":"Chen, W., Chang, B., Li, L. & Chan, L. Patatin-like phospholipase domain-containing 3\/adiponutrin deficiency in mice is not associated with fatty liver disease. Hepatology 52, 1134\u20131142. https:\/\/doi.org\/10.1002\/hep.23812 (2010).","journal-title":"Hepatology"},{"key":"47839_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1194\/jlr.M011205","volume":"52","author":"MK Basantani","year":"2011","unstructured":"Basantani, M. K. et al. Pnpla3\/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J. Lipid Res. 52, 318\u2013329. https:\/\/doi.org\/10.1194\/jlr.M011205 (2011).","journal-title":"J. Lipid Res."},{"key":"47839_CR21","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1002\/hep.29041","volume":"65","author":"FV Bruschi","year":"2017","unstructured":"Bruschi, F. V. et al. The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells. Hepatology 65, 1875\u20131890. https:\/\/doi.org\/10.1002\/hep.29041 (2017).","journal-title":"Hepatology"},{"key":"47839_CR22","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1172\/JCI65179","volume":"122","author":"JZ Li","year":"2012","unstructured":"Li, J. Z. et al. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J. Clin. Investig. 122, 4130\u20134144. https:\/\/doi.org\/10.1172\/JCI65179 (2012).","journal-title":"J. Clin. Investig."},{"key":"47839_CR23","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/hep.30583","volume":"69","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Kory, N., BasuRay, S., Cohen, J. C. & Hobbs, H. H. PNPLA3, CGI-58, and inhibition of hepatic triglyceride hydrolysis in mice. Hepatology. 69, 2427\u20132441. https:\/\/doi.org\/10.1002\/hep.30583 (2019).","journal-title":"Hepatology"},{"key":"47839_CR24","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s42255-019-0066-3","volume":"1","author":"A Yang","year":"2019","unstructured":"Yang, A., Mottillo, E. P., Mladenovic-Lucas, L., Zhou, L. & Granneman, J. G. Dynamic interactions of ABHD5 with PNPLA3 regulate triacylglycerol metabolism in brown adipocytes. Nat. Metab. 1, 560\u2013569. https:\/\/doi.org\/10.1038\/s42255-019-0066-3 (2019).","journal-title":"Nat. Metab."},{"key":"47839_CR25","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jhep.2012.07.030","volume":"57","author":"C Pirazzi","year":"2012","unstructured":"Pirazzi, C. et al. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. J. Hepatol. 57, 1276\u20131282. https:\/\/doi.org\/10.1016\/j.jhep.2012.07.030 (2012).","journal-title":"J. Hepatol."},{"key":"47839_CR26","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1210\/clinem\/dgaa729","volume":"106","author":"PK Luukkonen","year":"2021","unstructured":"Luukkonen, P. K. et al. The PNPLA3-I148M variant confers an antiatherogenic lipid profile in insulin-resistant patients. J. Clin. Endocrinol. Metab. 106, e300\u2013e315. https:\/\/doi.org\/10.1210\/clinem\/dgaa729 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"47839_CR27","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1038\/s41467-024-49224-x","volume":"15","author":"SM Johnson","year":"2024","unstructured":"Johnson, S. M. et al. PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein. Nat. Commun. 15, 4847. https:\/\/doi.org\/10.1038\/s41467-024-49224-x (2024).","journal-title":"Nat. Commun."},{"key":"47839_CR28","doi-asserted-by":"publisher","first-page":"116371","DOI":"10.1016\/j.celrep.2025.116371","volume":"44","author":"DJ Sherman","year":"2025","unstructured":"Sherman, D. J. et al. PNPLA3-I148M is a neomorph that interferes with two primary hepatic triglyceride clearance pathways. Cell. Rep. 44, 116371. https:\/\/doi.org\/10.1016\/j.celrep.2025.116371 (2025).","journal-title":"Cell. Rep."},{"key":"47839_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher, G., Byrne, C. D. & Tilg, H. MASLD: A systemic metabolic disorder with cardiovascular and malignant complications. Gut. 73, 691\u2013702. https:\/\/doi.org\/10.1136\/gutjnl-2023-330595 (2024).","journal-title":"Gut"},{"key":"47839_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/dsi23-0010","volume":"37","author":"ZM Younossi","year":"2024","unstructured":"Younossi, Z. M. & Henry, L. Understanding the burden of nonalcoholic fatty liver disease: Time for action. Diabetes Spectr. 37, 9\u201319. https:\/\/doi.org\/10.2337\/dsi23-0010 (2024).","journal-title":"Diabetes Spectr."},{"key":"47839_CR31","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","volume":"42","author":"A Deprince","year":"2020","unstructured":"Deprince, A., Haas, J. T. & Staels, B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol. Metab. 42, 101092. https:\/\/doi.org\/10.1016\/j.molmet.2020.101092 (2020).","journal-title":"Mol. Metab."},{"key":"47839_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327672","author":"A Mantovani","year":"2022","unstructured":"Mantovani, A. et al. Non-alcoholic fatty liver disease and risk of new-onset heart failure: An updated meta-analysis of about 11 million individuals. Gut https:\/\/doi.org\/10.1136\/gutjnl-2022-327672 (2022).","journal-title":"Gut"},{"key":"47839_CR33","doi-asserted-by":"publisher","first-page":"10206","DOI":"10.1038\/ncomms10206","volume":"6","author":"CS Tang","year":"2015","unstructured":"Tang, C. S. et al. Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese. Nat. Commun. 6, 10206. https:\/\/doi.org\/10.1038\/ncomms10206 (2015).","journal-title":"Nat. Commun."},{"key":"47839_CR34","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/ng.3977","volume":"49","author":"DJ Liu","year":"2017","unstructured":"Liu, D. J. et al. Exome-wide association study of plasma lipids in >\u2009300,000 individuals. Nat. Genet. 49, 1758\u20131766. https:\/\/doi.org\/10.1038\/ng.3977 (2017).","journal-title":"Nat. Genet."},{"key":"47839_CR35","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/hep4.1319","volume":"3","author":"M Brouwers","year":"2019","unstructured":"Brouwers, M. et al. Relationship between nonalcoholic fatty liver disease susceptibility genes and coronary artery disease. Hepatol. Commun. 3, 587\u2013596. https:\/\/doi.org\/10.1002\/hep4.1319 (2019).","journal-title":"Hepatol. Commun."},{"key":"47839_CR36","doi-asserted-by":"publisher","first-page":"108186","DOI":"10.1016\/j.jbc.2025.108186","volume":"301","author":"G Teskey","year":"2025","unstructured":"Teskey, G. et al. Lipid droplet targeting of the lipase coactivator ABHD5 and the fatty liver disease-causing variant PNPLA3 I148M is required to promote liver steatosis. J. Biol. Chem. 301, 108186. https:\/\/doi.org\/10.1016\/j.jbc.2025.108186 (2025).","journal-title":"J. Biol. Chem."},{"key":"47839_CR37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nm.4346","volume":"23","author":"DA Giles","year":"2017","unstructured":"Giles, D. A. et al. Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling. Nat. Med. 23, 829\u2013838. https:\/\/doi.org\/10.1038\/nm.4346 (2017).","journal-title":"Nat. Med."},{"key":"47839_CR38","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.molmet.2016.09.008","volume":"5","author":"DA Giles","year":"2016","unstructured":"Giles, D. A. et al. Modulation of ambient temperature promotes inflammation and initiates atherosclerosis in wild type C57BL\/6 mice. Mol. Metab. 5, 1121\u20131130. https:\/\/doi.org\/10.1016\/j.molmet.2016.09.008 (2016).","journal-title":"Mol. Metab."},{"key":"47839_CR39","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/hep.29273","volume":"66","author":"S BasuRay","year":"2017","unstructured":"BasuRay, S., Smagris, E., Cohen, J. C. & Hobbs, H. H. The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation. Hepatology 66, 1111\u20131124. https:\/\/doi.org\/10.1002\/hep.29273 (2017).","journal-title":"Hepatology"},{"key":"47839_CR40","doi-asserted-by":"publisher","first-page":"9521","DOI":"10.1073\/pnas.1901974116","volume":"116","author":"S BasuRay","year":"2019","unstructured":"BasuRay, S., Wang, Y., Smagris, E., Cohen, J. C. & Hobbs, H. H. Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis. Proc. Natl. Acad. Sci. U. S. A. 116, 9521\u20139526. https:\/\/doi.org\/10.1073\/pnas.1901974116 (2019).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"47839_CR41","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1074\/jbc.M110.180711","volume":"286","author":"JG Granneman","year":"2011","unstructured":"Granneman, J. G., Moore, H. P., Mottillo, E. P., Zhu, Z. & Zhou, L. Interactions of perilipin-5 (Plin5) with adipose triglyceride lipase. J. Biol. Chem. 286, 5126\u20135135. https:\/\/doi.org\/10.1074\/jbc.M110.180711 (2011).","journal-title":"J. Biol. Chem."},{"key":"47839_CR42","doi-asserted-by":"publisher","unstructured":"Zhou, Y., Khan, H., Xiao, J. & Cheang, W. S. Effects of arachidonic acid metabolites on cardiovascular health and disease. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms222112029 (2021).","DOI":"10.3390\/ijms222112029"},{"key":"47839_CR43","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s12876-021-02020-z","volume":"21","author":"N Akuta","year":"2021","unstructured":"Akuta, N. et al. PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD. BMC Gastroenterol. 21, 434. https:\/\/doi.org\/10.1186\/s12876-021-02020-z (2021).","journal-title":"BMC Gastroenterol."},{"key":"47839_CR44","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1038\/s44325-026-00104-x","volume":"3","author":"T Fukase","year":"2026","unstructured":"Fukase, T. & Dohi, T. A narrative review of impacts of apolipoproteins on atherosclerotic coronary plaques. NPJ Cardiovasc. Health. 3, 2948\u20132836. https:\/\/doi.org\/10.1038\/s44325-026-00104-x (2026).","journal-title":"NPJ Cardiovasc. Health"},{"key":"47839_CR45","doi-asserted-by":"publisher","first-page":"101450","DOI":"10.1016\/j.jhepr.2025.101450","volume":"7","author":"L Jegodzinski","year":"2025","unstructured":"Jegodzinski, L. et al. PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feeding. JHEP Rep. 7, 101450. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101450 (2025).","journal-title":"JHEP Rep."},{"key":"47839_CR46","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1194\/jlr.M700279-JLR200","volume":"48","author":"JM Brown","year":"2007","unstructured":"Brown, J. M. et al. CGI-58 facilitates the mobilization of cytoplasmic triglyceride for lipoprotein secretion in hepatoma cells. J. Lipid Res. 48, 2295\u20132305. https:\/\/doi.org\/10.1194\/jlr.M700279-JLR200 (2007).","journal-title":"J. Lipid Res."},{"key":"47839_CR47","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/hep.24402","volume":"54","author":"A Qiao","year":"2011","unstructured":"Qiao, A. et al. Mouse patatin-like phospholipase domain-containing 3 influences systemic lipid and glucose homeostasis. Hepatology 54, 509\u2013521. https:\/\/doi.org\/10.1002\/hep.24402 (2011).","journal-title":"Hepatology"},{"key":"47839_CR48","doi-asserted-by":"publisher","unstructured":"Johansson, L. E. et al. Larsson Ca Fau - R\u00e5stam, Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity. Eur. J. Endocrinol. 159, 577\u2013583. https:\/\/doi.org\/10.1530\/EJE-08-0426 (2008).","DOI":"10.1530\/EJE-08-0426"},{"key":"47839_CR49","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/hep.31609","volume":"73","author":"BA Banini","year":"2021","unstructured":"Banini, B. A. et al. Identification of a metabolic, transcriptomic, and molecular signature of patatin-like phospholipase domain containing 3-mediated acceleration of steatohepatitis. Hepatology. 73, 1290\u20131306. https:\/\/doi.org\/10.1002\/hep.31609 (2021).","journal-title":"Hepatology"},{"key":"47839_CR50","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/jcmm.14839","volume":"24","author":"S Yuan","year":"2019","unstructured":"Yuan, S. et al. PNPLA3 I148M mediates the regulatory effect of NF-kB on inflammation in PA\u2010treated HepG2 cells. J. Cell. Mol. Med. 24, 1541\u20131552. https:\/\/doi.org\/10.1111\/jcmm.14839 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"47839_CR51","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s11739-025-03895-6","volume":"20","author":"M Huang","year":"2025","unstructured":"Huang, M. et al. Global burden and risk factors of MASLD: trends from 1990 to 2021 and predictions to 2030. Intern. Emerg. Med. 20, 1013\u20131024. https:\/\/doi.org\/10.1007\/s11739-025-03895-6 (2025).","journal-title":"Intern. Emerg. Med."},{"key":"47839_CR52","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1038\/s41591-024-03284-0","volume":"30","author":"O Jamialahmadi","year":"2024","unstructured":"Jamialahmadi, O. et al. Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease. Nat. Med. 30, 3614\u20133623. https:\/\/doi.org\/10.1038\/s41591-024-03284-0 (2024).","journal-title":"Nat. Med."},{"key":"47839_CR53","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1056\/NEJMc2402341","volume":"391","author":"E Fabbrini","year":"2024","unstructured":"Fabbrini, E. et al. Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD. N. Engl. J. Med. 391, 475\u2013476 (2024).","journal-title":"N. Engl. J. Med."},{"key":"47839_CR54","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"Percie du Sert","year":"2020","unstructured":"Percie du Sert. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 18, e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410 (2020).","journal-title":"PLoS Biol."},{"key":"47839_CR55","doi-asserted-by":"crossref","unstructured":"Rio, D. C. A., Hannon, M. & Nilsen, G. K. J. T.W. Purification of RNA using TRIzol (TRI reagent). Cold Spring Harb. Protoc. (2010).","DOI":"10.1101\/pdb.prot5439"},{"key":"47839_CR56","doi-asserted-by":"publisher","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25, 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","DOI":"10.1006\/meth.2001.1262"},{"key":"47839_CR57","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch, J., Lees, M. & Stanley, G. H. S. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497\u2013509. https:\/\/doi.org\/10.1016\/s0021-9258(18)64849-5 (1957).","journal-title":"J. Biol. Chem."},{"key":"47839_CR58","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","volume":"49","author":"V Matyash","year":"2008","unstructured":"Matyash, V., Liebisch, G., Kurzchalia, T. V., Shevchenko, A. & Schwudke, D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 49, 1137\u20131146. https:\/\/doi.org\/10.1194\/jlr.D700041-JLR200 (2008).","journal-title":"J. Lipid Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47839-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47839-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47839-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:02:20Z","timestamp":1783602140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47839-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,10]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47839"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47839-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,10]]},"assertion":[{"value":"26 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21361"}}